Clinical Trial Update: Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension [Phase 1]

View source ↗

Summary

Phase 1 randomized, double-blind, placebo-controlled exploratory study to assess safety, tolerability, pharmacokinetics, and hemodynamic response to a single 30…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Vasomera (PB1046)

Snippet

Sponsor: PhaseBio Pharmaceuticals Inc. | Conditions: Essential Hypertension | Phase 1 | Status: COMPLETED